Position in FTRE
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$10,725,461
+$1,782,768 QoQ
Shares Held
1,138,584
+119.6% QoQ
Ownership
1.20%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ALGERT GLOBAL LLC holds $437,724,004 across 106 Biotechnology names. FTRE ranks #9 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
827,454 | $22,920,475 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
135,460 | $22,895,449 | |
| 3 | SNDX |
Syndax Pharmaceuticals Inc
|
928,568 | $21,691,348 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
363,984 | $21,151,110 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
283,921 | $21,083,973 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
264,200 | $15,363,230 | |
| 7 | MRNA |
Moderna, Inc.
|
237,418 | $12,060,834 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.\DE
|
563,999 | $11,031,820 |
All Filings in FTRE
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,725,461 | 1,138,584 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $8,942,693 | 518,417 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,513,251 | 1,011,075 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,147,573 | 1,042,019 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,460,665 | 325,916 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,116,202 | 59,850 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $199,603 | 8,552 | Shares | Sole | 2024-08-15 | |
| No filing history on record for this holder in this stock. | ||||||